Innate Pharma S.A. Sponsored ADR IPHA

1.70 0.00 0.00% as of 25 Sep
Market cap
$188.8M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
208.09 139.89 197.85 245.13 173.22 141.78 106.92 100.07 87.40 38.82
Receivables
26.90 18.17 179.64 20.99 24.92 21.79 40.40 60.13 5.38 14.03
Inventory
0.54 — — — — — — — — —
Other current assets
6.66 7.62 — — — — — — — —
Total current assets
242.19 165.69 377.50 266.12 198.13 163.57 147.33 160.19 92.78 52.85
Property, Plant, Equpment (Net)
9.57 12.93 12.07 13.07 13.36 12.04 9.00 6.84 5.55 4.93
Long-Term Investments
33.10 70.39 41.55 41.45 44.47 47.18 37.00 10.60 11.13 11.83
Long-term receivables
— — — 18.75 34.06 35.28 14.85 11.42 10.09 0.28
Goodwill and Intangible Assets (Total)
9.55 55.65 99.83 108.60 52.88 52.28 1.64 0.45 — —
Long Term Assets (Tax, Deferred)
— — 1.84 1.44 8.10 5.95 9.03 9.75 — —
Long-term assets (Other)
1.99 2.60 0.10 0.10 0.17 0.18 0.16 0.09 0.62 1.07
Total non-current assets
— — 155.39 183.41 153.04 152.91 71.68 39.16 27.40 18.11
Total Assets
296.40 0.00 532.89 449.52 351.17 316.47 219.00 199.35 120.18 70.96
Accounts Payable
16.42 24.06 108.24 55.44 33.74 33.80 22.03 18.42 17.32 17.02
Current Part of Debt
0.94 1.17 1.59 2.39 2.45 36.38 2.21 9.67 9.42 9.96
Current Revenue (Deferred)
— — 96.96 54.62 12.91 14.79 6.91 6.35 0.67 3.20
Other current liabilities
63.11 63.82 25.56 23.99 2.86 9.54 12.40 8.46 8.28 11.29
Total current liabilities
80.46 89.05 232.35 136.44 51.96 94.51 43.55 42.90 35.69 41.46
Long Term Debt (Total)
3.17 4.55 3.75 18.58 19.36 15.98 42.30 33.50 24.12 15.58
Non-current Revenue (Deferred)
— 104.83 80.42 45.18 37.32 30.07 8.35 5.00 3.06 —
Pension and Post-Retirement Liabilities
— — 4.37 4.21 4.77 3.52 2.69 2.64 2.95 2.18
Long Term Tax Liability (Deferred)
— — 1.84 1.44 8.10 5.95 9.03 9.75 — —
Non-current Liabilities (Other)
122.06 5.28 12.65 0.16 51.49 39.34 56.04 49.39 44.80 36.30
Total non-current liabilities
— — 103.03 69.58 121.04 94.85 118.40 100.28 74.93 54.05
Total liabilities
205.69 203.70 335.38 206.02 173.00 189.36 161.95 143.18 110.62 95.52
Additional Paid In Capital
— — 354.22 413.97 425.09 443.92 399.99 415.88 423.08 461.65
Common Stock (Net)
2.84 3.47 3.78 4.41 4.51 4.71 4.23 4.38 4.54 5.30
Retained Earnings
(109.05) (183.11) (159.19) (174.35) (251.83) (322.06) (348.02) (364.62) (418.08) (492.77)
Shareholders Equity (Other)
— — (1.30) (0.53) 0.41 0.54 0.86 0.54 0.03 1.26
Common Equity (Total)
90.70 103.56 197.51 243.50 178.17 127.11 57.05 56.17 9.56 (24.56)
Shareholders Equity (Total)
90.70 103.56 197.51 243.51 178.17 127.11 57.05 56.17 9.56 (24.56)
Shareholders Equity and Liabilities (Total)
— — 532.89 449.52 351.17 316.47 219.00 199.35 120.18 70.96
Shares (Common)
— — 64.04 78.83 79.00 79.56 79.54 80.45 83.84 93.72
Shareholders Equity (Tangible)
— — 97.68 134.90 125.30 74.83 55.41 55.72 9.56 (24.56)
Net Debt
(203.99) (134.18) (192.51) (224.16) (151.41) (89.42) (62.41) (56.89) (53.86) (13.28)
Total Debt
4.11 5.71 5.34 20.97 21.80 52.35 44.52 43.18 33.54 25.54

Fold the line items

In millions of $ except per-share values · columns are period end dates